The diagnostic and therapeutic achievements in radiopharmaceuticals and nuclear medicine instrumentation – PET, SPECT, MR, CT and their hypbrids PET-CT and SPECT-CT – are the result of the interdisciplinary research efforts of cell-biologists, chemists, pharmacologists, physicists, computer-scientists, engineers, nuclear medicine physicians, and oncologists. The clinical implications of these achievements have made nuclear medicine indispensable in the management of cancer. This superbly illustrated text on modern nuclear medicine applications in the diagnosis and treatment of cancer describes the state of the art and the current position of nuclear medicine in the light of these recent developments. It is intended as a valuable update also for non-nuclear medicine specialists working in oncology. Nuclear medicine as part of molecular imaging and therapy has changed radically in the last decade. The growing importance and clinical impact of these changes in the near future has impelled the internationally renowned editors and contributors to put them on record in Advances in Nuclear Oncology.
Section I: Biology of Cancer 1. What is Cancer? 2. Targets
Section II: Diagnostic Applications 3. Primary Brain Tumours 4. Head and Neck Cancer 5. Lung Cancer 6. Esophageal Cancer 7. Colorectal Cancer 8. Prostate Cancer 9. Ovarian Cancer 10. Breast Cancer 11. Thyroid Cancer 12. Adrenal Cancer 13. Neuroendocrine Gastroenteropancreatic Tumors 14. Lymphoma 15. Bone and Soft Tissue Tumors 16. Malignant Melanoma17. Cancer of Unknown Primary
Section III: Therapeutic Applications 18. Differentiated Thyroid Cancer 19. Medullary Thyroid Cancer 20. Lymphoma 21. Neuroendocrine Tumors 22. Bone Metastases 23. Liver Tumors 24. Colorectal Cancer 25. Brain Tumors 26. Ovarian Cancer
Section IV: Methods and Technology 27. New Instrumentation 28. New Radiopharmaceuticals 29. Radiopharmaceuticals for Therapy 30. New Concepts in Dosimetry and Protection 31. Advances in Nuclear Medicine Imaging in Oncology 32. Nuclear Medicine-Guided Radiotherapy